Home » News and Events » News & Studies » PHARMExcel are pleased to announce the publication of the safety and immunogenicity data from the UK’s Covboost trial.
PHARMExcel are pleased to announce the publication of the safety and immunogenicity data from the UK’s Covboost trial.